Patent Assignment
Reel/Frame 062779/0784
Assignment of Assignor's Interest
Recorded: 2023-02-23
Pages: 6
Assignors
YAO, YIHONG
Executed: 2019-08-26
HUANG, JIAQI
Executed: 2019-08-26
ZHU, SHIGUI
Executed: 2019-08-26
ZHU, WEI
Executed: 2019-08-26
YAO, XIN
Executed: 2019-08-26
LI, ZHIYUAN
Executed: 2019-08-26
ZHANG, LI
Executed: 2019-08-26
ZHU, LIN
Executed: 2019-08-26
MA, ANYUN
Executed: 2019-08-26
WEI, YUTIAN
Executed: 2019-08-26
LI, YANFENG
Executed: 2019-08-26
WANG, QINGXIA
Executed: 2019-08-26
HE, JIAPING
Executed: 2019-08-26
Assignees
CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
LEVEL 5, BUILDING 1, 333 GUIPING ROAD, XUHUI DISTRICT, SHANGHAI, 200233, CHINA
CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
BUILDING 2, SUITE 301, 1619 HUISHAN ROAD, HUISHAN DISTRICT, WUXI, JIANGSU, 217174, CHINA
Covered Property
(1)
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application:
18/173,187 →
Publication:
US 2023/0242613
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 062779/0928 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 062780/0017 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP HK LIMITED
To: CELLULAR BIOMEDICINE GROUP, INC.
Reel/Frame 062780/0143 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →